Abstract

Tuberculosis is becoming one of the major health concerns worldwide. Although combinatorial therapy with various anti-tuberculosis drugs is a promising treatment option, increasing drug resistance and co-infections is prompting us to develop new medications or explore anti-mycobacterial compounds from bioactive natural products. Previous studies have proved that various natural compounds, especially polyphenols have anti-mycobacterial activities. However, the detailed molecular mechanism remains unknown. In our study, we utilized the quantitative proteomic strategy to explore the dynamic changes at proteome and phosphoproteome levels with the treatment of flavonoid quercetin and non-flavonoid caffeic acid by using the non-pathogenic model organism M. smegmatis as a model. These two polyphenols are abundant compounds in nature with potential therapeutic effects on infectious diseases. Both polyphenols induced protein changes in the metabolic process of macromolecules and organic compounds. Meantime, quercetin treatment may cause changes in methyltransferase activity and nucleic acid binding. In addition, a reduction in phosphorylation level was observed in several mycobacterial serine/threonine-protein kinases in response to quercetin treatment. In conclusion, our study uncovered the potential antimycobacterial mechanisms of polyphenols, providing new insights into therapeutic strategy in this infectious disease.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.